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ABSTRACT
Introduction Healthcare providers in resource- limited 
settings rely on the presence of tachypnoea and chest 
indrawing to establish a diagnosis of pneumonia in 
children. We aimed to determine the test characteristics 
of commonly assessed signs and symptoms for the 
radiographic diagnosis of pneumonia in children 0–59 
months of age.
Methods We conducted an analysis using patient- 
level pooled data from 41 shared datasets of paediatric 
pneumonia. We included hospital- based studies in which 
>80% of children had chest radiography performed. 
Primary endpoint pneumonia (presence of dense opacity 
occupying a portion or entire lobe of the lung or presence 
of pleural effusion on chest radiograph) was used as the 
reference criterion radiographic standard. We assessed 
the sensitivity, specificity, and likelihood ratios for clinical 
findings, and combinations of findings, for the diagnosis of 
primary endpoint pneumonia among children 0–59 months 
of age.
Results Ten studies met inclusion criteria comprising 
15 029 children; 24.9% (n=3743) had radiographic 
pneumonia. The presence of age- based tachypnoea 
demonstrated a sensitivity of 0.92 and a specificity of 0.22 
while lower chest indrawing revealed a sensitivity of 0.74 
and specificity of 0.15 for the diagnosis of radiographic 
pneumonia. The sensitivity and specificity for oxygen 
saturation <90% was 0.40 and 0.67, respectively, and 
was 0.17 and 0.88 for oxygen saturation <85%. Specificity 
was improved when individual clinical factors such as 
tachypnoea, fever and hypoxaemia were combined, 
however, the sensitivity was lower.
Conclusions No single sign or symptom was strongly 
associated with radiographic primary end point pneumonia 
in children. Performance characteristics were improved by 
combining individual signs and symptoms.
INTRODUCTION
Pneumonia is the leading cause of morbidity 
and mortality among children 1–59 months of 
age worldwide.1 2 Annually, there are over 800 
000 deaths from pneumonia among children 
worldwide.2 Such morbidity and mortality 
from childhood pneumonia disproportion-
ately affects children in low- income and 
middle- income countries, with nearly 90% 
Key questions
What is already known?
 ► Pneumonia is the leading cause of morbidity and 
mortality among children 1–59 months of age 
worldwide.
 ► The diagnosis of childhood pneumonia is often es-
tablished based on clinical findings, as the definitive 
aetiological diagnosis can only be made using inva-
sive testing.
 ► Antibiotic treatment decisions for children with 
suspected pneumonia in low- income and middle- 
income countries rely largely on clinical findings, 
including tachypnoea and chest indrawing.
What are the new findings?
 ► Our study of over 15 000 children from geographi-
cally diverse parts of the world is the largest to date 
to assess the test characteristics of clinical signs 
and symptoms for radiographic pneumonia among 
children 0–59 months of age.
 ► Individual findings commonly used to identify pneu-
monia in resource- limited settings, including tachy-
pnoea and lower chest indrawing, had low specificity 
for the diagnosis of radiographic pneumonia.
 ► The combination of tachypnoea and fever, tachy-
pnoea and hypoxaemia, and fever and hypoxaemia 
led to improved specificity with only a modest decre-
ment in sensitivity for radiographic pneumonia.
What do the new findings imply?
 ► Individual symptoms and physical examination find-
ings are not highly predictive of primary endpoint 
pneumonia on chest radiograph.
 ► Combining temperature, respiratory rate, and oxy-
gen saturation improves specificity in the identifica-
tion of radiographic pneumonia.
 ► The diagnostic performance of a combination of 
signs and symptoms should be explored in a pro-
spective fashion to allow for a judicious approach 
to antibiotic treatment in children with suspected 
pneumonia.
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of pneumonia- related deaths occurring in sub- Saharan 
Africa and South and Southeastern Asia alone.2 3 Despite 
the large global burden of disease of childhood pneu-
monia, a commonly agreed upon standardised approach 
to the diagnosis of pneumonia is lacking.4
The diagnosis of childhood pneumonia is often estab-
lished based on clinical findings, as the definitive diag-
nosis can only be made using invasive testing such as 
lung biopsies, which are reserved for patients in whom 
traditional therapeutics have failed.5 As such, chest radi-
ography is often used in clinical practice for the diagnosis 
of childhood pneumonia and has been used as a refer-
ence standard in previous investigations.6–10 In a large, 
multicountry study in Asia and sub- Saharan Africa, chest 
radiography correlated with clinically diagnosed pneu-
monia in over half of patients included.11 Nevertheless, 
the routine use of chest radiography for the diagnosis 
of childhood pneumonia in the outpatient setting is 
not recommended by the Infectious Disease Society of 
America.5 Similarly, the World Health Organization’s 
(WHO) integrated management of childhood illness 
(IMCI) chart booklet used in many low- income and 
middle- income countries, recommends the diagnosis of 
pneumonia be made clinically, with reliance on tachy-
pnoea or lower chest indrawing in a child with cough or 
difficulty breathing.12 13 However, recent analyses suggest 
that the sensitivity (54%–62%) and specificity (59%–
64%) of tachypnoea and sensitivity (38%–48%) and spec-
ificity (72%–80%) of lower chest indrawing is lower than 
originally estimated.9 10 14 Concerns around the low speci-
ficity of the WHO pneumonia signs, and potential excess 
antibiotic prescribing, prompted further evaluation of 
these clinical criteria for the diagnosis of pneumonia in 
children.
The development of sensitive and specific diagnostic 
clinical criteria for childhood pneumonia is imperative 
as chest radiography is not routinely available in many 
low- and middle- income countries. Previous systematic 
reviews evaluating the utility of symptoms and physical 
examination findings for the diagnosis of childhood 
pneumonia have relied on data reported in published 
articles, without access to individual patient- level data.9 10 
Additionally, the overwhelming majority of these investi-
gations were conducted in high- income countries. The 
reliance on predetermined cut- points from published 
articles for clinical criteria such as respiratory rate (RR) 
and oxygen saturation (SpO2) may lead to imprecision in 
the analysis of diagnostic clinical criteria for childhood 
pneumonia.
With the aim of better understanding the clinical diag-
nostic criteria for childhood pneumonia, the WHO estab-
lished the Pneumonia REsearch Partnership to Assess 
WHO Recommendations (PREPARE) study group. The 
PREPARE study group obtained patient- level data from 
30 study groups, comprising 41 separate datasets on 
childhood pneumonia from across the world. Using the 
large, representative PREPARE dataset, our objective was 
to determine the sensitivity and specificity of key clinical 
features and combination of clinical features in the diag-
nosis of childhood pneumonia against a radiological 
reference standard. Accurate identification of children 
with pneumonia using clinical factors could potentially 
allow providers to more accurately diagnose childhood 
pneumonia and, subsequently, more appropriately target 
antibiotic therapy.
METHODS
Study design
We conducted an analysis using datasets from the WHO’s 
PREPARE study group. The WHO PREPARE study group 
assembled datasets through retrospective identification 
of primary data on childhood pneumonia from over 20 
low- and middle- income countries in Asia, Africa and 
Latin America as well as two high- income countries (ie, 
the USA and Australia). Study sites were considered for 
inclusion in WHO PREPARE study group if they included 
data from control arms of vaccine trials, community- 
based cohorts, and hospital- based studies with clinical 
and epidemiological data collected. Potential study sites 
were identified from a list of contributors to a systematic 
review of global burden of hospital admissions for severe 
acute lower respiratory infections in children.15 Based 
on a review of the paediatric pneumonia literature, we 
identified 50 groups who were involved in pneumonia 
research who had published articles between 2005 and 
2018. These groups had conducted pneumonia research 
with and without interventions, randomised controlled 
trials, epidemiological studies, and vaccine trials. We 
invited all 50 study groups to participate by attending 
an inception meeting in Ferny- Voltaire, France. Repre-
sentatives from 38 groups attended that meeting where 
each investigator presented their site data. As a result of 
that meeting, 30 study groups agreed to participate and 
provided 41 unique databases for the WHO PREPARE 
study group. Datasets were limited to include only data 
on children 0–59 months of age, despite potentially 
containing data from older children.
For this study, to include datasets in which chest radi-
ography was performed in a generalisable fashion, we 
limited our analysis to datasets of hospital- based studies 
that included data on chest radiography and had a chest 
radiography performed in >80% of cases. Studies in 
which chest radiography was performed in <80% of cases 
may have suffered from selection bias as chest radiog-
raphy may have been performed only in children with 
severe illness and at higher risk of pneumonia and were 
excluded. Community- based studies were not included as 
chest radiography was rarely performed.
Patient and public involvement statement
The development of the research question was informed 
by the large disease burden of pneumonia among chil-
dren worldwide. Patients were not involved in the design, 
recruitment, or conduct of the study. Results of this 
study will be made publicly available through publication 
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where study participants may access them. Patients were 
not advisers in this study.
Pneumonia case definition
Datasets were included in this analysis if they included 
data on children presenting acutely with cough or diffi-
culty breathing and included pneumonia as defined 
by the WHO radiological criteria for primary endpoint 
pneumonia6 (n=8) or if they used lobar consolidation on 
chest radiography as diagnostic criteria for pneumonia 
(n=2). Though originally created for use in vaccine trials, 
primary endpoint pneumonia has been applied to large 
cohorts of children with pneumonia in several low- and 
middle- income countries with good inter- rater relia-
bility.16 A majority of the datasets (n=6) included in this 
analysis enrolled children with tachypnoea, as this is the 
primary determinant of pneumonia based on the WHO 
IMCI chart booklet. Primary endpoint pneumonia was 
selected as the radiographic reference standard as it is 
clearly defined, is reliable across studies, is independent 
of predictor clinical variables that are often studied in 
work evaluating childhood pneumonia, is a clear indica-
tion of pneumonia and not viral acute lower respiratory 
tract infection, and highlights bacterial pneumonia that 
requires antibiotic treatment. Lobar consolidation was 
used as a reference standard in two included datasets and 
has shown high inter- rater reliability among paediatric 
radiologists in prospective studies.17 All radiographs in 
the included studies were interpreted by a radiologist; 
many of the studies required review by two or more radi-
ologists.
Data analysis
Using radiographic pneumonia as the reference 
standard, we evaluated the sensitivity, specificity, and 
likelihood ratios (LRs) for individual clinical findings. 
We calculated 95% CIs for all +LR and −LRs. Candidate 
variables from patients’ histories that were used to calcu-
late test characteristics included history of cough, fever, 
difficulty breathing, vomiting, and poor feeding. We eval-
uated the test characteristics of tachypnoea as defined by 
the WHO IMCI age- specific cutoffs (ie, RR of ≥60 breaths 
per minutes in children <2 months old, >50 breaths per 
minute in children 2–11 months old, and >40 breaths 
per minute in children 12–59 months old)18 as well as 
the addition of five and 10 respirations per minute to the 
age- specific WHO classification of tachypnoea.
Using radiographic pneumonia as the reference stan-
dard, we also evaluated the test characteristics of lower 
chest indrawing, nasal flaring, grunting, wheezing, body 
temperature, SpO2, presence of rales or crepitations, 
inability to drink, presence of convulsions, cyanosis, head 
nodding/bobbing, presence of irritability, lethargy and 
presence of any danger sign (ie, inability to drink, convul-
sions, cyanosis, head nodding/bobbing, irritability, 
abnormally sleepy, lethargy, nasal flaring, grunting, and 
SpO2 <90%). We stratified analyses by age (<2 months, 
2–11 months, and 12–59 months) and by the presence 
or absence of wheezing. We assessed the test characteris-
tics of varying age- specific RR and SpO2 in patients both 
with and without wheezing to eliminate children who 
may have asthma who are sometimes included in studies 
evaluating pneumonia. We also assessed the sensitivity, 
specificity, and LRs of combinations of clinical signs 
and symptoms compared with the reference standard 
of radiographic pneumonia. We had a study power of 
>95% to detect a difference in radiographic pneumonia 
of at least 7% between children who had some clinical 
features of pneumonia (eg, presence of chest indrawing, 
any danger sign, temperature >38°C, or SpO2 <90%) and 
those who did not have these clinical features. All anal-
yses were conducted using Stata V.14 (StataCorp, College 
Station, TX, USA).
RESULTS
Of the 41 separate datasets, 26 were hospital based, of 
which 10 met inclusion criteria, containing a total of 15 
029 patients (figure 1). The mean age of patients was 
Figure 1 Hospital- based studies including children 0 to <59 
months of age. aChest radiography not performed or data 
regarding presence of pneumonia/infiltrate not recorded. 
bRadiographic pneumonia in 3743 patients (24.9%). 
PREPARE, Pneumonia REsearch Partnership to Assess WHO 
Recommendations.
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13.0 months (standard deviation ±12.3) with median 
of 9.0 months (4.4–16.9). Details regarding the setting 
and patient population for the 10 included datasets are 
shown in table 1. Of the 15 029 patients included, 24.9% 
(n=3743) had radiographic pneumonia.
The sensitivity and specificity of individual symptoms 
and physical examination findings for the diagnosis of 
radiographic pneumonia are shown in table 2. No single 
sign or symptom was strongly associated with radio-
graphic pneumonia. The presence of poor feeding (+LR 
1.67 (95%CI 1.29 to 2.16)), axillary/body temperature 
>38°C (+LR 1.36 (95%CI 1.31 to 1.41)), head nodding/
bobbing (+LR 1.84 (95%CI 1.38 to 2.45)), grunting (+LR 
1.72 (95%CI 1.27 to 2.33)), and hypoxaemia at SpO2 
<85% (+LR 1.42 [95%CI 1.27 to 1.59)) were weakly asso-
ciated with the presence of radiographic pneumonia, 
while the absence of the following features was associ-
ated with a lower likelihood of radiographic pneumonia: 
axillary/body temperature >38°C (−LR 0.77 (95%CI 0.74 
to 0.80)), rales/crepitations (−LR 0.73 (95%CI 0.66 to 
0.80)), and SpO2 <95% (−LR 0.83 (95%CI 0.78 to 0.88)).
Age- specific RR thresholds were neither highly sensitive 
nor specific for the radiographic diagnosis of pneumonia 
in the overall cohort and among the subset of chil-
dren without wheezing (table 3). Among children 2–11 
months of age, those with RR >60 breaths per minute 
Table 1 Study characteristics
Study Location
Age 
range Inclusion and exclusion criteria
Sample 
size
Radiographic 
pneumonia,
N (%)
Definition of 
pneumonia by 
chest radiograph
Puumalainen et al 
and Arcay, et al. 
(ARIVAC)48 49
Philippines 6 weeks 
to 59 
months
Tachypnoea*, lower chest indrawing 
(severe pneumonia)† or cyanosis 
and/or inability to drink (very severe 
pneumonia)‡
1153 187 (16.2) Primary end 
point pneumonia 
(PEP)§
Basnet et al50 Nepal 2–35 
months
Cough <14 days and/or difficulty 
breathing ≤72 hours with presence of 
lower chest indrawing, provided lower 
chest indrawing persisted after 3 doses 
of bronchodilators.
551 135 (24.5) Lobar 
pneumonia/
consolidation¶
Gentile et al51 Argentina 0–59 
months
Children hospitalised with pneumonia. 401 201 (50.1) PEP§
Gessner et al52 Indonesia 0–24 
months
WHO defined non- severe** and severe 
pneumonia†.
5814 1025 (17.6) PEP§
Hortal et al53 Uruguay 0–59 
months
Children hospitalised with acute lower 
respiratory tract infection with chest 
X- ray performed.
811 412 (50.8) PEP§
Tan et al54 Indonesia <5 years All children with diagnosis of 
pneumonia and having >1 of the 
following: fever, cough, dyspnoea, or 
tachypnoea*.
1251 128 (10.2) Lobar 
pneumonia/
consolidation¶
Neuman, et al24 USA 0–59 
months
Children with chest X- ray performed 
for suspicion of pneumonia. Excluded 
children with chronic conditions.
1796 161 (9.0) PEP§
O'Grady et al55 Central 
Australia
0–59 
months
Child with cough with tachypnoea* 
and/or chest indrawing†. Excluded 
children with wheezing and chronic 
conditions.
147 40 (27.2) PEP§
Ferrero et al56 Argentina 1–59 
months
WHO defined non- severe** and severe 
pneumonia†. Excluded hospital- 
acquired pneumonia.
2085 1123 (53.9) PEP§
Turner et al57 Thailand 0–2 years WHO defined non- severe** and severe 
pneumonia†.
1020 331 (32.5) PEP§
*Tachypnoea: respiratory rate ≥60 per minute in infants <2 months old, ≥50 per minute in infants 2–11 months old, or ≥40 per minute in 
children 12–59 months of age.
†Severe pneumonia (old WHO pneumonia classification): cough and/or fast breathing with lower chest indrawing.
‡Very severe pneumonia (old WHO pneumonia classification): one or more danger sign including abnormally sleepy, lethargy, central 
cyanosis, inability to drink, convulsions, head nodding/bobbing, nasal flaring or grunting.
§PEP: a dense opacity that may be a fluffy consolidation of a portion or whole of a lobe or of the entire lung, often containing air 
bronchograms and sometimes associated with pleural effusion.
¶Lobar pneumonia or consolidation: Chest X- ray findings showing lobar pneumonia or consolidation.
**Non- severe pneumonia: cough and fast breathing, defined as respiratory rate of >50 per minute in children 2–11 months old or >40 
per minute in children 12–59 months old.
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were more likely to have radiographic pneumonia (+LR 
1.08 (95%CI 1.03 to 1.14)), while those with RR <60 were 
less likely to have radiographic pneumonia (−LR 0.91 
(95%CI 0.86 to 0.97)).
The test characteristics of SpO2 for radiographic 
pneumonia for all children and those without wheezing 
are shown in online supplementary table 1. Sensitivity 
decreased and specificity increased with increasing levels 
of hypoxaemia, although no single threshold had optimal 
test characteristics for the identification of radiographic 
pneumonia.
The combinations of varying degrees of hypoxaemia, 
fever and tachypnoea are shown in tables 4–6. At each 
SpO2 category, specificity increased with increasing RR. 
Among children with SpO2 <90%, children with RRs 
≥10 breaths per minute above the WHO threshold for 
age- defined tachypnoea were slightly more likely to 
have radiographic pneumonia (+LR 1.40 (95%CI 1.28 
to 1.53)), while those without this degree of tachypnoea 
were less likely to have radiographic pneumonia (−LR 
0.92 (95%CI 0.90 to 0.94)) (table 4). Among the subset 
of children with temperature >38°C, those with an RR 
≥10 breaths per minute above the WHO threshold for 
age- defined tachypnoea were slightly more likely to have 
radiographic pneumonia (+LR 1.24 (95%CI 1.14 to 
1.35)) (table 5). The combination of temperature >38°C 
and SpO2 <85% was highly specific for radiographic 
pneumonia (specificity 0.96, (95% CI 0.96 to 0.97)) while 
the sensitivity was quite low (sensitivity 0.07, (95% CI 0.06 
to 0.08)) (table 6).
DISCUSSION
Our study of over 15 000 children from geographically 
diverse parts of the world is the largest to date assessing 
the test characteristics of clinical signs and symptoms for 
radiographic pneumonia among children 0–59 months 
of age. We observed that individual findings commonly 
Table 3 Test characteristics of varying respiratory rates (RRs) by age group among all children and those without wheezing*
RR
Patients with 
RR above 
threshold, n
Patients with 
radiographic 
pneumonia, n Sensitivity Specificity
Positive likelihood 
ratio (95% CI)
Negative 
likelihood ratio 
(95% CI)
All children
Age <2 months (n=1073)
  RR >60 650 104 0.60 0.39 0.98 (0.86 to 1.12) 1.03 (0.84 to 1.25)
  RR >65 357 63 0.36 0.67 1.11 (0.89 to 1.38) 0.95 (0.84 to 1.07)
  RR >70 182 30 0.17 0.83 1.02 (0.71 to 1.46) 1.00 (0.93 to 1.07)
Age 2–11 months (n=7145)
  RR >50 5986 1187 0.85 0.17 1.02 (1.00 to 1.05) 0.89 (0.77 to 1.02)
  RR >55 4926 982 0.71 0.31 1.03 (0.99 to 1.07) 0.94 (0.86 to 1.03)
  RR >60 3717 772 0.55 0.49 1.08 (1.03 to 1.14) 0.91 (0.86 to 0.97)
Age 12–59 months (n=4260)
  RR >40 3140 715 0.74 0.26 1.00 (0.96 to 1.04) 1.00 (0.89 to 1.13)
  RR >45 2685 603 0.62 0.37 0.98 (0.93 to 1.04) 1.03 (0.94 to 1.13)
  RR >50 2268 499 0.51 0.46 0.96 (0.89 to 1.02) 1.05 (0.98 to 1.13)
Children without wheezing
Age <2 months (n=937)
  RR >60 570 85 0.60 0.39 0.99 (0.86 to 1.14) 1.02 (0.81 to 1.27)
  RR >65 318 54 0.38 0.67 1.15 (0.92 to 1.46) 0.92 (0.80 to 1.06)
  RR >70 162 26 0.18 0.83 1.08 (0.74 to 1.58) 0.98 (0.90 to 1.07)
Age 2–11 months (n=5340)
  RR >50 4449 886 0.84 0.17 1.01 (0.99 to 1.04) 0.93 (0.79 to 1.08)
  RR >55 3650 730 0.69 0.32 1.02 (0.97 to 1.07) 0.96 (0.86 to 1.06)
  RR >60 2731 571 0.54 0.50 1.08 (1.01 to 1.15) 0.92 (0.86 to 0.99)
Age 12–59 months (n=3225)
  RR >40 2270 540 0.70 0.29 0.98 (0.93 to 1.04) 1.04 (0.92 to 1.17)
  RR >45 1937 449 0.58 0.39 0.95 (0.89 to 1.02) 1.07 (0.98 to 1.18)
  RR >50 1612 368 0.47 0.49 0.93 (0.86 to 1.02) 1.07 (0.99 to 1.16)
Bold values are statistically significant.
*182 missing values for RR were excluded from the analysis.
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used to identify pneumonia in resource- limited settings, 
including tachypnoea and chest indrawing, had poor 
specificity for the diagnosis of radiographic pneumonia. 
The test characteristics of all signs and symptoms did 
not materially differ based on the presence or absence 
of wheeze. Our study demonstrates that no individual 
symptom or physical examination finding was strongly 
associated with radiographic pneumonia in children. 
Extreme levels of hypoxaemia were highly specific for 
radiographic pneumonia, although sensitivity was low. 
Lower thresholds of hypoxaemia commonly used in 
clinical settings (ie, <95% and <90%)19 demonstrated 
moderate sensitivity and specificity for the identification 
of radiographic pneumonia.
The WHO guideline recommends oral amoxicillin 
treatment in children 2–59 months of age with chest 
indrawing.12 20 In our analysis, chest indrawing alone 
was not specific for the radiographic diagnosis of pneu-
monia. It has been suggested that children with chest 
indrawing and signs of severe respiratory distress, oxygen 
desaturations, moderate malnutrition, and unknown 
HIV- status in HIV- endemic areas be monitored daily or 
referred for inpatient management given their risk for 
decompensation.21 In a large prospective pneumonia 
aetiology study in low- and middle- income countries, 
tachypnoea, hypoxaemia, crackles, and fever were all 
independently associated with an abnormal chest radio-
graph.11 Oxygen desaturation was the most specific single 
sign for radiographic pneumonia in our study. In a small, 
retrospective study of 147 children in Rwanda, oxygen 
desaturation was significantly associated with radiographic 
pneumonia.22 In a larger prospective study of nearly 400 
children in Norway, hypoxaemia (defined as SpO2 <92%) 
independently predicted radiographic pneumonia and 
was the only clinical feature that predicted radiographic 
pneumonia.23 If available, SpO2 should be measured in 
children evaluated for pneumonia as the presence of 
extreme levels of hypoxaemia is highly specific for the 
diagnosis of radiographic pneumonia.
Although tachypnoea is used to assess for pneumonia 
in many resource- limited settings, our data showed 
that commonly used, age- specific RR thresholds were 
neither sensitive nor specific for the identification of 
radiographic pneumonia in children. This finding adds 
further support to the body of evidence suggesting that 
tachypnoea should not be used as an isolated finding 
Table 4 Test characteristics of varying respiratory rates (RRs) with SpO2 levels in children
RR and SpO2
Patients 
with RR 
above 
threshold, n 
(n=9360)
Radiographic 
pneumonia, 
n (n=2444) Sensitivity Specificity
Positive likelihood 
ratio (95% CI)
Negative likelihood 
ratio (95% CI)
SpO2 <95%
RR >age specific cut- off* 6519 1460 0.60 0.46 1.11 (1.07 to 1.15) 0.87 (0.83 to 0.92)
RR >5 above age- specific 
cut- off†
5529 1242 0.51 0.54 1.11 (1.06 to 1.16) 0.90 (0.87 to 0.95)
RR >10 above age- 
specific cut- off‡
4400 1016 0.42 0.64 1.15 (1.09 to 1.22) 0.91 (0.88 to 0.95)
SpO2 <90%
RR >age- specific cut- off* 2835 731 0.30 0.78 1.33 (1.24 to 1.43) 0.90 (0.88 to 0.93)
RR >5 above age- specific 
cut- off†
2465 641 0.26 0.81 1.35 (1.25 to 1.46) 0.92 (0.89 to 0.94)
RR >10 above age- 
specific cut- off‡
2064 551 0.23 0.84 1.40 (1.28 to 1.53) 0.92 (0.90 to 0.94)
SpO2 <85%
RR >age- specific cut- off* 1204 342 0.14 0.91 1.52 (1.36 to 1.71) 0.95 (0.93 to 0.96)
RR >5 above age- specific 
cut- off†
1049 305 0.12 0.92 1.57 (1.39 to 1.79) 0.95 (0.94 to 0.97)
RR >10 above age- 
specific cut- off‡
887 263 0.11 0.93 1.62 (1.41 to 1.86) 0.96 (0.94 to 0.97)
Bold values are statistically significant.
*RR of ≥60 per minute in infants <2 months old, >50 per minute in infants 2–11 months old, or >40 per minute in children 
12–59 months old.
†RR of ≥65 per minute in infants <2 months old, >55 per minute in infants 2–11 months old, or >45 per minute in children 
12–59 months old.
‡RR of ≥70 per minute in infants <2 months old, >60 per minute in infants 2–11 months old, >50 per minute in children 12–59 
months old.
SPO2, oxygen saturation.
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to diagnose pneumonia and subsequently determine 
which children would benefit from antibiotic treat-
ment.9 10 24 25 Radiographic pneumonia, though often 
used as the reference standard for the diagnosis of pneu-
monia, should be interpreted in the context of its limita-
tions including the potential delayed manifestations of 
radiographic findings, inability to reliably distinguish 
bacterial and viral infections, and variable inter- rater 
reliability among radiologists for certain findings sugges-
tive of pneumonia.17 Our investigation used primary end 
point radiographic pneumonia, which was developed 
for vaccine trials to identify pneumonia that could be 
prevented by Streptococcus pneumoniae and Haemophilus 
influenzae B vaccines and it became a useful and a sensi-
tive tool to evaluate vaccine outcomes.26 27 Primary end 
point radiographic pneumonia is a subset of all cases of 
clinical pneumonia.11 Our finding that tachypnoea is not 
strongly associated with radiographic pneumonia might 
partially explain the variable results from randomised 
trials comparing amoxicillin and placebo among chil-
dren with fast breathing pneumonia.28–30 Furthermore, 
many children receiving a diagnosis of pneumonia in 
resource- limited settings may harbour other respira-
tory illnesses such as asthma or other viral infections as 
demonstrated by the Pneumonia Etiology Research for 
Child Health study group.31
Table 5 Test characteristics of varying respiratory rates (RRs) with fever (temperature >38°C) in children
RR and fever
Patients 
with RR 
above 
threshold, 
n (n=9410)
Radiographic 
pneumonia, 
n (n=2335) Sensitivity Specificity
Positive likelihood 
ratio (95% CI)
Negative likelihood 
ratio (95% CI)
Afebrile (temperature <38°C)
RR >age- specific cut- off* 5809 1073 0.46 0.51 0.94 (0.89 to 0.99) 1.06 (1.01 to 1.10)
RR >5 above age- specific 
cut- off†
4619 856 0.37 0.61 0.94 (0.89 to 1.00) 1.04 (1.00 to 1.07)
RR >10 above age- specific 
cut- off‡
3479 649 0.28 0.71 0.95 (0.88 to 1.02) 1.02 (0.99 to 1.05)
Febrile (temperature >38°C)
RR >age- specific cut- off* 3601 787 0.34 0.71 1.16 (1.09 to 1.24) 0.93 (0.91 to 0.96)
RR >5 above age- specific 
cut- off†
3045 678 0.29 0.76 1.19 (1.10 to 1.28) 0.94 (0.91 to 0.97)
RR >10 above age- specific 
cut- off‡
2446 564 0.24 0.81 1.24 (1.14 to 1.35) 0.94 (0.92 to 0.97)
Bold values are statistically significant.
*RR of ≥60 per minute in infants <2 months old, >50 per minute in infants 2–11 months old or >40 per minute in children 
12–59 months old.
†RR of ≥65 per minute in infants <2 months old, >55 per minute in infants 2–11 months old, or >45 per minute in children 
12–59 months old.
‡RR of ≥70 per minute in infants <2 months old, >60 per minute in infants 2–11 months old, >50 per minute in children 12–59 
months old.
Table 6 Test characteristics of varying oxygen saturations (SpO2) without and with fever (temperature >38°C) in children
Fever and SpO2
Patients with 
symptoms, n 
(n=11 547)
Radiographic 
pneumonia, n 
(n=2323) Sensitivity Specificity
Positive likelihood 
ratio (95% CI)
Negative likelihood 
ratio (95% CI)
Afebrile (temperature <38°C)
  SpO2 <95% 4421 870 0.37 0.62 0.97 (0.92 to 1.03) 1.02 (0.98 to 1.05)
  SpO2 <90% 1827 407 0.18 0.85 1.14 (1.03 to 1.26) 0.97 (0.95 to 0.99)
  SpO2 <85% 810 192 0.08 0.93 1.23 (1.06 to 1.44) 0.98 (0.97 to 1.00)
Febrile (temperature >38°C)
  SpO2 <95% 2636 666 0.29 0.79 1.34 (1.24 to 1.45) 0.91 (0.88 to 0.93)
  SpO2 <90% 1178 340 0.15 0.91 1.61 (1.43 to 1.81) 0.94 (0.92 to 0.96)
  SpO2 <85% 520 170 0.07 0.96 1.93 (1.61 to 2.30) 0.96 (0.95 to 0.97)
Bold values are statistically significant.
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Treatment decisions for children with suspected pneu-
monia in low- income and middle- income countries 
rely largely on clinical findings, including tachypnoea 
and chest indrawing.12 13 This allows community health 
workers and healthcare providers at primary level health 
facilities to make decisions around antibiotic admin-
istration and the need for referral in areas with scarce 
resources. However, other signs, such as hypoxaemia, are 
critical to identify as it has been shown to be associated with 
radiographic pneumonia,9 24 and carries up to a fivefold 
increased risk of mortality when compared with children 
without hypoxaemia in low- and middle- income coun-
tries.32–36 Our study identified extreme levels of hypox-
aemia as highly specific for radiographic pneumonia. 
Though the WHO IMCI chart booklet recommends use 
of pulse oximetry when available,12 many low- resource 
settings lack this tool.37 38 However, the recent devel-
opment of low- cost technologies for pulse oximetry,39 
including hardware attached to mobile phones,40–42 may 
expand its use in resource- limited settings.
The major strength of our aggregated database 
containing individual patient- level data is our ability 
to evaluate the test characteristics of combinations of 
signs, symptoms, and physical examination findings for 
the radiographic diagnosis of pneumonia. Prior single- 
centre studies have not been powered to identify which 
combinations of clinical findings could be used to iden-
tify radiographic pneumonia.24 43–47 Additionally, prior 
meta- analyses investigating the test characteristics of 
clinical signs and symptoms for the prediction of radio-
graphic pneumonia observed that no single sign or 
symptom was highly accurate for the identification of 
radiographic pneumonia,9 10 and discussed the impetus 
for future studies to allow for the assessment of a combi-
nation of signs and symptoms to improve the care of 
children with suspected pneumonia. In this study, by 
aggregating patient- level data from ten investigations, 
we observed that by combining certain signs and symp-
toms, including tachypnoea, oxygen desaturation, and 
fever, we were able to improve the discriminator ability to 
identify radiographic pneumonia. The diagnostic perfor-
mance of a combination of signs and symptoms should 
be explored in a prospective fashion to allow for a judi-
cious approach to antibiotic treatment in children with 
suspected pneumonia.
Limitations
The results of this analysis should be interpreted in the 
context of their limitations. First, as many studies used 
in this analysis used the WHO IMCI definition of tachyp-
noea and lower chest indrawing as an inclusion criterion, 
there may be overestimation of the true sensitivity and 
specificity of tachypnoea in the radiographic diagnosis 
of childhood pneumonia. Also, the inclusion criterion 
of tachypnoea as defined by WHO thresholds limited 
our ability to assess the test characteristics of RRs below 
the WHO thresholds in the radiographic diagnosis of 
pneumonia. Second, there was no common standardised 
approach to define radiographic pneumonia across all 10 
studies, though most studies included in this analysis used 
primary endpoint pneumonia or lobar consolidation, 
which is part of end point pneumonia definition.16 The 
inclusion of both primary end point pneumonia and lobar 
consolidation as the reference standard may have intro-
duced some heterogeneity to our findings but improves 
the generalisability of our findings to more practical 
clinical settings. Third, lack of uniformity of recording 
some signs and symptoms across included studies may 
have led to overestimation or underestimation of the test 
characteristics for the signs and symptoms evaluated in 
this analysis. Fourth, we did not conduct formal statistical 
analyses to account for heterogeneity in the included 
studies’ inclusion and exclusion criteria. Fifth, there 
was a high degree of heterogeneity with respect to study 
types, settings, type of clinician performing the evalua-
tion, and patient population. Lastly, our findings may not 
be as applicable to extremely resource- limited settings in 
which chest radiography is not routinely available.
CONCLUSIONS
In this study, including >15 000 children 0–59 months 
of age, we observed that no individual symptom or phys-
ical examination finding was predictive of end point 
radiographic pneumonia. The presence of tachypnoea 
as an isolated finding was neither sensitive nor specific, 
while extreme levels of hypoxaemia was a specific finding 
among children with radiographic pneumonia. Combi-
nations of commonly used vital signs including tempera-
ture, RR and SpO2 improved the specificity for the iden-
tification of radiographic pneumonia.
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